Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Single Center Study to Evaluate the Immunopharmacological Effects of Rituximab in Patients With Atopic Dermatitis

NCT00267826 is registered in ClinicalTrials.gov with University of Bern as lead sponsor.

NCT NCT00267826
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00267826 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Single Center Study to Evaluate the Immunopharmacological Effects of Rituximab in Patients With Atopic Dermatitis
Lead sponsor
University of Bern
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2005
Completion date
December 31, 2006
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dermatitis, atopic